Additional file 1 of Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

Li, Huayi; Peng, Zikun; Zhu, Jianqing; Zhao, Weidong; Huang, Yi; An, Ruifang; Zheng, Hong; Qu, Pengpeng; Wang, Li; Zhou, Qi; Wang, Danbo; Lou, Ge; Wang, Jing; Wang, Ke; Kong, Beihua; Xie, Xing; Yin, Rutie; Low, John; Rozita, Abdul Malik; Sen, Lim Chun; Meng, Yong Chee; Kiong, Kho Swee; Liu, Jihong; Liang, Zhiqing; Lv, Weiguo; Zhu, Yaping; Hu, Weiguo; Sun, Wei; Su, Jingya; Wang, Qiqi; Zang, Rongyu; Ma, Ding; Gao, Qinglei

doi:10.6084/m9.figshare.25844374.v1

12916_2024_3409_MOESM1_ESM.docx (235.74 kB)

Additional file 1 of Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

journal contribution

posted on 2024-05-17, 03:42 authored by Huayi Li, Zikun Peng, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, Beihua Kong, Xing Xie, Rutie Yin, John Low, Abdul Malik Rozita, Lim Chun Sen, Yong Chee Meng, Kho Swee Kiong, Jihong Liu, Zhiqing Liang, Weiguo Lv, Yaping Zhu, Weiguo Hu, Wei Sun, Jingya Su, Qiqi Wang, Rongyu Zang, Ding Ma, Qinglei Gao

Additional file 1. Study protocol of the L-MOCA trial.

Funding

AstraZeneca

History

Usage metrics

Keywords

Platinum-sensitive relapsed ovarian cancer Olaparib PD-L1 expression BRCA1/2 PARP inhibitors Homologous recombination deficiency L-MOCA trial Biomarker

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

Funding

AstraZeneca

History

Usage metrics

Categories

Keywords

Licence

Exports